Micheliolide ameliorates colon cancer cachexia by modulating gut microbiota-immune signaling via Phocaeicola vulgatus enrichment.
Saved in:
| Title: | Micheliolide ameliorates colon cancer cachexia by modulating gut microbiota-immune signaling via Phocaeicola vulgatus enrichment. |
|---|---|
| Authors: | Youn HY; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea., Park S; Center for Natural Product Systems Biology, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea., Min H; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea., Ngoc NB; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea., Kim YH; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea., Cha KH; Center for Natural Product Systems Biology, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea.; Natural Product Applied Science, Korea Institute of Science and Technology (KIST) School, University of Science and Technology (UST), Gangneung, Gangwon-Do, Republic of Korea., Park YT; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea.; Natural Product Applied Science, Korea Institute of Science and Technology (KIST) School, University of Science and Technology (UST), Gangneung, Gangwon-Do, Republic of Korea., Kwon HY; Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan, Chungcheongnam-Do, Republic of Korea., Lee CG; Center for Natural Product Systems Biology, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea. cglee0708@kist.re.kr.; Natural Product Applied Science, Korea Institute of Science and Technology (KIST) School, University of Science and Technology (UST), Gangneung, Gangwon-Do, Republic of Korea. cglee0708@kist.re.kr., Kim M; Center for Natural Product Efficacy Optimization, Natural Product Drug Development Division, Korea Institute of Science and Technology (KIST), 679 Saimdang-Ro, Gangneung, Gangwon-Do, Republic of Korea. g-sstainer@kist.re.kr.; Natural Product Applied Science, Korea Institute of Science and Technology (KIST) School, University of Science and Technology (UST), Gangneung, Gangwon-Do, Republic of Korea. g-sstainer@kist.re.kr.; Department of Convergence Medicine, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-Do, Republic of Korea. g-sstainer@kist.re.kr. |
| Source: | Microbiome [Microbiome] 2026 May 05; Vol. 14 (1). Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101615147 Publication Model: Electronic Cited Medium: Internet ISSN: 2049-2618 (Electronic) Linking ISSN: 20492618 NLM ISO Abbreviation: Microbiome Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
